Apexigen partners with and licenses its programs and intellectual property to biotechnology and pharmaceutical companies and other entities to meet our strategic objectives. We have partnered with and licensed certain of our intellectual property to certain of the entities identified below to advance our programs and technology and facilitate clinical research of our drug candidates to advance the treatment of patients with cancer.
Apexigen is interested in
- Strategic collaborations and out-licenses of rights to advance the discovery and development of innovative oncology drugs
- In-license and co-development opportunities for oncology therapeutics
Apexigen welcomes inquiries from companies interested in partnering and licensing relationships. Contact us at email@example.com.